Confirmed Speakers for 2017
Yasmina Abdiche, PhD
Chief Scientific Officer
Gregory Adams, PhD
John Anderson, PhD
GOSHCC Professor of Experimental Paediatric Oncology, Honorary Consultant Oncologist
UCL Great Ormond Street Institute of Child Health
Raiees Andrabi, PhD
Research Associate, Burton Lab
The Scripps Research Institute
Joseph Arboleda-Velasquez, MD, PhD
Harvard Medical School
Frederick Arce Vargas, MD, PhD
University College London Cancer Institute
Natalia Arenas Ramirez, PhD
Post-doctoral Researcher, Department of Immunology
University Hospital Zurich
Jasi Atwal, PhD
Isabelle Aubert, PhD
Senior Scientist, Sunnybrook Research Institute, Professor, Department of Laboratory Medicine and Pathobiology
University of Toronto
George Badescu, PhD
Vice President Scientific Affairs, Business Development
Chris Bailey-Kellogg, PhD
Professor, Computer Science
Raffaella Balocco Mattavelli, PhD
Group Lead, INN, Essential Medicines and Health Products
World Health Organization (WHO)
Jennifer Bath, PhD
Senior Director, Antibody Discovery
Jannick Bendtsen, PhD
Vice President of Technology Services
M. Jack Borrok, PhD
Leila Boustany, PhD
Senior Scientist I, Cancer Immunology
Carlo Boutton, PhD
Director Technology & Information Management
Andrew Bradbury, PhD
David Bramhill, PhD
Bramhill Biological Consulting, LLC
Keith Breinlinger, PhD
General Manager, Life Sciences & Senior Vice President, Engineering
Berkeley Lights, Inc.
John Burke, PhD
Co-Founder, President, and CEO
Applied BioMath, LLC
Dennis Burton, PhD
Professor and Chairman, Department of Immunology & Microbial Science
John Cambier, PhD
Distinguished Professor and Chair
University of Colorado SOM
Paul Carter, PhD
Senior Director and Staff Scientist, Antibody Engineering
Natalie Castellana, PhD
Chief Executive Officer
Digital Proteomics LLC
Patrick Chames, PhD
Principal Investigator, Cancer Research Center of Marseille (CRCM)
Kartik Chandran, PhD
Professor of Microbiology and Immunology, Harold and Muriel Block Faculty Scholar in Virology
Albert Einstein College of Medicine
Chun-Nan Chen, PhD
Single Cell Technology, Inc.
Kerry Chester, PhD
Professor of Molecular Medicine
UCL Cancer Institute
Ann Cheung, Ph.D.
Head of Biology
Peter Chin, M.D.
Group Medical Director, Neuroscience, SPECTRUM Medical Unit, US Medical Affairs
Kathryn Ching, Ph.D.
Mark Chiu, Ph.D.
Associate Director of Development
Daniel Christ, Ph.D.
Associate Professor, Director Centre for Targeted Therapy
Garvan Institute of Medical Research
Mark Cobbold, M.D., Ph.D.
Associate Professor of Medicine, Center for Cancer Immunology
MGH Cancer Center
Jennifer Cochran, Ph.D.
Co-Founder and Director, Nodus Therapeutics and Associate Professor, Bioengineering & Chemical Engineering
Fernando Concha-Benavente, M.D., Ph.D.
UPMC Hillman Cancer Center
Sarah Crome, Ph.D.
Banting Postdoctoral Fellow
Princess Margaret Cancer Centre, University Health Network
James Crowe, Jr., M.D.
Director, Vanderbilt Vaccine Center
Vanderbilt University Medical Center
Cristina D'Abramo, Ph.D.
Assistant Investigator, The Litwin-Zucker Research Center for the Study of Alzheimer's Disease
The Feinstein Institute for Medical Research, North Shore - LIJ
Rony Dahan, Ph.D.
Weizmann Institute of Science
Peter Davies, Ph.D.
Scientific Director Litwin/Zucker Center for Alzheimer’s Disease and Memory Disorders, Feinstein Institute for Medical Research
Hans de Haard, Ph.D.
Vincenzo De Laurenzi, M.D., Ph.D.
Associate Professor in Clinical Biochemistry and Molecular Biology, Department of Biomedical Sciences
Universita' "G. d'Annunzio" Chieti-Pesca
Brandon DeKosky, Ph.D.
Assistant Professor of Chemical Engineering and Pharmaceutical Chemistry
The University of Kansas
Dimiter Dimitrov, Ph.D.
Professor and Director, Center for Antibody Therapeutics (CAT)
University of Pittsburgh Medical School
Thomas Duensing, Ph.D.
Chief Technology Officer
Thomas Duhen, Ph.D.
Senior Research Scientist
Ryan Emerson, Ph.D.
Edgar Engleman, M.D.
Professor of Pathology and Medicine
Stanford University School of Medicine
James Ernst, Ph.D.
Senior Scientist & Group Leader, Department of Protein Sciences
Robert Ferris, M.D., Ph.D.
Hillman Professor of Oncology and Director
Jeremy Fry, D.Phil
Director of Sales
Yang-Xin Fu, M.D., Ph.D.
Professor of Pathology
UT Southwestern Medical Center
Michael Gallo, Ph.D.
Innovative Targeting Solutions
Julia Gavrilyuk, Ph.D.
Principal Scientist, Discovery Chemistry
George Georgiou, Ph.D.
Professor, Laura Jennings Turner Chair in Engineering
The University of Texas at Austin
Frank Grosveld, Ph.D.
Professor of Cell Biology, Erasmus MC, and Founder of Harbour Antibodies BV
Erasmus MC and Harbour BioMed BV
Jeffrey Guise, Ph.D.
Wilson Sonsini Goodrich & Rosati
Claes Gustafsson, Ph.D.
Chief Commercial Officer and Co-Founder
ATUM (formerly DNA2.0)
Benjamin Hackel, Ph.D.
Chemical Engineering and Materials Science
University of Minnesota
Kenta Haraya, Ph.D.
Scientist, Research Division, Biologics Discovery
Chugai Pharmaceutical Co., Ltd.
Bill Harriman, Ph.D.
VP, Antibody Discovery Services
Albert Heck, Ph.D.
Professor, Science Faculty
Guy Hermans, Ph.D.
Christoph Hock, M.D.
Professor and Director, Institute for Regenerative Medicine
University of Zurich
Erik Hofman, Ph.D.
Senior Scientist, Research Department
Kevin Hollevoet, Ph.D.
Group Leader and Postdoc, Therapeutic and Diagnostic Antibodies
University of Leuven
Dirk Hose, M.D.
Head, Multiple Myeloma Research Laboratory, Department of Internal Medicine
Chung-Ming Hsieh, D.Sc.
Executive Director, Biologics Discovery Boston
Merck Research Laboratories
Mickey Hu, Ph.D.
Principal Investigator and Director of Discovery Oncology
Panorama Institute of Molecular Medicine
James Huston, Ph.D.
Chairman, The Antibody Society, Managing Member
Huston BioConsulting, LLC
Christel Iffland, Ph.D.
Vice President, Antibody Technologies
Tomoyuki Igawa, Ph.D.
Head of Biologics Discovery, Research Division
Chugai Pharmaceutical Co., Ltd., Japan
Bryan Irving, Ph.D.
Vice President, Cancer Immunology
Tony Jackson, Ph.D.
Senior Lecturer, Biochemistry
University of Cambridge
Syd Johnson, Ph.D.
Vice President, Antibody Engineering
David Johnson, PhD, MBA
Founder and CEO
Martina Jones, Ph.D.
Operations Manager - National Biologics Facility and Deputy Director - ARC Training Centre for Biopharm, AIBN
The University of Queensland
Christyne Kane, Ph.D.
Senior Scientist, Biologics
AbbVie Global Biologics
Guna Kannan, Ph.D.
Director, Biologics-Antibody Engineering, Pharmaceutical Development
Kurt Klimpel, Ph.D.
Field Application Specialist, Product Development
Sebastian Kreiter, M.D.
Director Immune Therapy Development Center, TRON, VP, Immunotherapy and Preclinical Research
BioNTech RNA Pharmaceuticals
Gerhard Kronke, M.D.
Professor of Translational Immunology, Department of Internal Medicine 3
University of Erlangen-Nuremberg
Chugai Pharmabody Research Pte. Ltd.
Pia Kvistborg, Ph.D.
Junior Group Leader, Department of Immunology
The Netherlands Cancer Institute
James Larrick, M.D., Ph.D.
Managing Director and Chief Medical Officer, Velocity Pharmaceutical Development
Panorama Research, Inc.
Greg Lazar, Ph.D.
Director and Senior Scientist, Antibody Engineering Department
Emily Le Proust, Ph.D.
Amy Lee, Ph.D.
Professor of Biochemistry and Molecular Biology
University of Southern California
Cynthia Lemere, Ph.D.
Associate Professor of Neurology, Ann Romney Center for Neurologic Diseases
Brigham & Women's Hospital/Harvard Medical
Qing Li, Ph.D.
Xin Lu, Ph.D.
John M. and Mary Jo Boler Assistant Professor, Department of Biological Sciences
University of Notre Dame
James Marks, M.D., Ph.D.
Professor and Vice Chairman
University of California, San Francisco
Thomas Marlovits, Ph.D.
Professor for Structural and Systems Biology, Institute of Molecular Biotechnology
Austrian Academy of Sciences (IMBA)
Eliezer Masliah, M.D.
Director, Division of Neurosciences
National Institutes of Aging, NIH
John McCafferty, Ph.D.
CEO and Founder
Brian McGuinness, Ph.D., MBA
Head of New Product & Business Opportunities
David Meininger, Ph.D.
Chief Business Officer
Anne Messer, Ph.D.
Neural Stem Cell Institute
Maria Navarro, M.D.
Project/Operations Manager - Business Development, Immuno-Oncology
Icell Kealex Therapeutics
David Oh, M.D., Ph.D.
Clinical Fellow, Division of Hematology/Oncology, Department of Medicine
Mats Ohlin, Ph.D.
Professor, Department of Immunotechnology & SciLifeLab
William Pardridge, M.D.
Distinguished Professor Emeritus / Founder and CSO
UCLA / ArmaGen
Paul Parren, Ph.D.
Professor, Department of Immunohematology and Blood Transfusion
Leiden University Medical Center
Andreas Pluckthun, Ph.D.
Professor and Director, Department of Biochemistry
Daniel Rader, M.D.
Seymour Gray Professor of Molecular Medicine, Perelman School of Medicine
University of Pennsylvania
Laura Ranum, Ph.D.
Director, Center for NeuroGenetics, Kitzman Family Professor of Molecular Genetics
University of Florida
Jeffrey Ravetch, Ph.D.
Professor, Laboratory of Molecular Genetics and Immunology
Janice Reichert, Ph.D.
Editor-in-Chief / Executive Director / Managing Director
mAbs / The Antibody Society / Reichert Biotechnology Consulting LLC
William Ridgway, M.D.
University of Cincinnati
Edward Roberts, Ph.D.
Joseph Rucker, Ph.D.
Vice President Research and Development
Vice President, R&D
Crescendo Biologics Ltd.
Kate Sasser, Ph.D.
Corporate Vice President, Biomarkers and Diagnostics
Genmab US, Inc.
Volker Schellenberger, Ph.D.
CEO and President
Tilman Schlothauer, Ph.D.
Senior Principal Scientist
Roche Innovation Center
Janine Schuurman, Ph.D.
Vice President, Research
Jamie Scott, M.D., Ph.D.
Professor and Canada Research Chair in Mol. Immuni., Molecular Biology & Biochemistry
Simon Fraser University
Eilon Sharon, Ph.D.
Postdoctoral Research Fellow, Genetics, Howard Hughes Medical Institute
Naglaa Shoukry, Ph.D.
Professor, Department of Medicine, Director, Viral Hepatitis Research Group
University of Montreal
Michael Sierks, Ph.D.
Professor, Chemical Engineering, Department of Chemical Engineering
Arizona State University
Vaughn Smider, M.D., Ph.D.
Assistant Professor, Molecular Medicine
Shautong Song, M.D., Ph.D.
Junichiro Sonoda, Ph.D.
Senior Scientist, Cancer Immunology
Julian Spallholz, Ph.D.
Professor, Nutritional Sciences
Texas Tech University
Jared Spidel, Ph.D.
Principal Scientist, Antibody Core Development
Martin Steegmaier, Ph.D.
Head of Discovery, Large Molecule Research, Roche Pharma Research and Early Development
Roche Innovation Center Munich
William Strohl, Ph.D.
Owner and President
BiStro Biotech Consulting LLC
Peter Tessier, Ph.D.
Albert M. Mattocks Professor of Pharmaceutical Sciences and Chemical Engineering, Biointerfaces Institute
University of Michigan
Scientific Services Manager, Biologics
Chemical Computing Group
Janssen Pharmaceuticals of Johnson & Johnson
Leendert Trouw, Ph.D.
Assistant Professor, Department of Immunohematology and Bloodtransfusion
Diane Van Hoorick, Ph.D.
Senior Project Leader, Technology
Max Vasquez, Ph.D.
Vice President, Computational Biology
Trudi Veldman, Ph.D.
Senior Director, Biologics
AbbVie Bioresearch Center
Wouter Verdurmen, Ph.D.
Research Associate, Department of Biochemistry, Radboud University Medical Center
Radboud Inst. for Molecular Life Science
Gestur Vidarsson, Ph.D.
Head of Immunoglobulin Research/PI, Experimental Immunohematology
Karthik Viswanathan, Ph.D.
Ernst Wagner, Ph.D.
Chair, Pharmaceutical Biotechnology, Center for System-based Drug Research
Ludwig Maximilans University
Taia Wang, M.D., Ph.D.
Assistant Professor, Medicine - Infectious Disease, Department of Internal Medicine
Cheng-I Wang, Ph.D.
Senior Principal Investigator, Singapore Immunology Network, Biomedical Sciences Institutes
Paul Weinreb, Ph.D.
Director, Biologics Drug Discovery
James Wells, Ph.D.
Professor, Pharmaceutical Chemistry, Harry and Dianna Hind Professor of Pharmaceutical Sciences
John Wheeler, Ph.D.
Principal Research Scientist, Janssen BioTherapeutics
Tim Whitehead, Ph.D.
Associate Professor, Chemical Engineering and Materials Science
Michigan State University
Nick Wilson, Ph.D.
Head of Immuno-Oncology
Karl Dane Wittrup, Ph.D.
C.P. Dubbs Professor of Chemical Eng. and Biol. En., Koch Institute for Integrative Cancer Research
Massachusetts Institute of Technology
Yingda Xu, Ph.D.
Associate Director, Protein Analytics
Masahiro Yasunaga, M.D., Ph.D.
Unit Leader, Division of Developmental Therapeutics
National Cancer Center
Bo Yu, Ph.D.
Co-founder and Chief Scientific Officer
Larix Bioscience LLC